In the last week, the Healthcare industry is up 3.2%, with Lytix Biopharma leading the way with a 33% gain. Meanwhile, SoftOx Solutions actually underperformed within the industry, shrinking 22% in the last week. In the past year, the industry is down 21%. Looking forward, earnings are forecast to grow by 54% annually.
Has the Norwegian Healthcare Sector valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 23 May 2025 | NOK 17.0b | NOK 3.9b | -NOK 1,271,478,490.11 | 27.6x | -13.4x | 4.4x |
Sun, 20 Apr 2025 | NOK 15.6b | NOK 3.5b | -NOK 1,218,256,741.19 | 17x | -12.8x | 4.5x |
Tue, 18 Mar 2025 | NOK 16.5b | NOK 3.4b | -NOK 1,238,657,384.96 | 17.4x | -13.3x | 4.8x |
Thu, 13 Feb 2025 | NOK 16.9b | NOK 3.8b | -NOK 1,154,043,057.31 | 24.8x | -14.7x | 4.5x |
Sat, 11 Jan 2025 | NOK 15.9b | NOK 3.8b | -NOK 1,111,500,890.51 | 24.7x | -14.3x | 4.2x |
Mon, 09 Dec 2024 | NOK 15.2b | NOK 3.7b | -NOK 983,369,007.08 | 21.6x | -15.5x | 4.1x |
Wed, 06 Nov 2024 | NOK 16.9b | NOK 4.0b | -NOK 986,207,812.93 | 19.7x | -17.1x | 4.2x |
Fri, 04 Oct 2024 | NOK 18.4b | NOK 4.0b | -NOK 963,568,080.45 | 20.4x | -19.1x | 4.6x |
Sun, 01 Sep 2024 | NOK 19.3b | NOK 4.0b | -NOK 879,596,177.70 | 18.7x | -21.9x | 4.8x |
Tue, 30 Jul 2024 | NOK 22.2b | NOK 4.0b | -NOK 982,876,285.39 | 16.8x | -22.6x | 5.5x |
Thu, 27 Jun 2024 | NOK 22.2b | NOK 4.1b | -NOK 949,885,989.54 | 15.5x | -23.3x | 5.4x |
Sat, 25 May 2024 | NOK 22.5b | NOK 4.2b | -NOK 1,167,111,325.35 | 17.6x | -19.3x | 5.3x |
Mon, 22 Apr 2024 | NOK 21.1b | NOK 4.2b | -NOK 1,137,079,771.34 | 27.1x | -18.6x | 5x |
Wed, 20 Mar 2024 | NOK 21.6b | NOK 4.2b | -NOK 1,084,436,183.79 | 27.7x | -19.9x | 5.1x |
Fri, 16 Feb 2024 | NOK 28.7b | NOK 4.1b | -NOK 1,273,563,127.43 | 24x | -22.5x | 7x |
Sun, 14 Jan 2024 | NOK 30.2b | NOK 4.1b | -NOK 1,580,016,420.00 | 23.9x | -19.1x | 7.4x |
Tue, 12 Dec 2023 | NOK 28.0b | NOK 4.1b | -NOK 1,599,272,503.00 | 21.3x | -17.5x | 6.8x |
Thu, 09 Nov 2023 | NOK 27.0b | NOK 3.7b | -NOK 1,738,236,205.00 | 25x | -15.6x | 7.4x |
Sat, 07 Oct 2023 | NOK 27.2b | NOK 3.6b | -NOK 1,805,595,555.00 | 33.3x | -15.1x | 7.6x |
Mon, 04 Sep 2023 | NOK 28.6b | NOK 3.6b | -NOK 1,776,905,210.00 | 31.9x | -16.1x | 8x |
Wed, 02 Aug 2023 | NOK 29.8b | NOK 3.4b | -NOK 1,821,859,620.00 | 30.3x | -16.4x | 8.8x |
Fri, 30 Jun 2023 | NOK 28.5b | NOK 3.4b | -NOK 1,801,402,723.00 | 43x | -15.8x | 8.4x |
Sun, 28 May 2023 | NOK 30.5b | NOK 3.4b | -NOK 1,832,198,782.00 | 43x | -16.7x | 9x |
Tue, 25 Apr 2023 | NOK 30.9b | NOK 3.1b | -NOK 1,781,079,629.00 | 31.5x | -17.4x | 9.8x |
Thu, 23 Mar 2023 | NOK 28.5b | NOK 3.1b | -NOK 1,870,171,228.00 | 31.1x | -15.2x | 9.2x |
Sat, 18 Feb 2023 | NOK 33.1b | NOK 3.7b | -NOK 1,896,302,614.00 | 32x | -17.4x | 9x |
Mon, 16 Jan 2023 | NOK 33.1b | NOK 3.6b | -NOK 1,834,241,045.00 | 35.4x | -18x | 9.2x |
Wed, 14 Dec 2022 | NOK 35.7b | NOK 3.6b | -NOK 1,829,082,967.00 | 35.3x | -19.5x | 10x |
Fri, 11 Nov 2022 | NOK 33.6b | NOK 3.5b | -NOK 1,752,498,305.00 | 39.6x | -19.2x | 9.5x |
Sun, 09 Oct 2022 | NOK 31.4b | NOK 3.5b | -NOK 1,776,305,740.00 | 58.2x | -17.7x | 9.1x |
Tue, 06 Sep 2022 | NOK 34.6b | NOK 3.4b | -NOK 1,757,986,202.00 | 56.8x | -19.7x | 10.1x |
Thu, 04 Aug 2022 | NOK 38.7b | NOK 3.3b | -NOK 1,739,731,684.00 | 90.2x | -22.2x | 11.8x |
Sat, 02 Jul 2022 | NOK 36.6b | NOK 3.3b | -NOK 1,727,604,806.00 | 56.9x | -21.2x | 11.2x |
Mon, 30 May 2022 | NOK 37.7b | NOK 3.6b | -NOK 1,320,943,420.00 | 48.1x | -28.6x | 10.5x |
-28.6x
Which industries have driven the changes within the Norwegian Healthcare sector?
NO Market | -0.22% | |
Healthcare | 0.26% | |
Healthcare Services | 12.31% | |
Medical Equipment | 2.13% | |
Pharma | 0.37% | |
Healthtech | -0.74% | |
Biotech | -2.10% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
MEDI Medistim | NOK 212.00 | 2.9% +NOK 109.5m | 13.7% | PE31.5x | |
INIFY INIFY Laboratories | NOK 7.30 | 12.3% +NOK 63.1m | -18.9% | n/a | |
LYTIX Lytix Biopharma | NOK 8.00 | 3.9% +NOK 20.5m | 50.9% | PS898.2x | |
ONCIN Oncoinvent | NOK 1.78 | 11.9% +NOK 18.6m | n/a | PS21.5x | |
OMDA Omda | NOK 52.80 | 1.5% +NOK 16.4m | 53.9% | PS2.4x |